Management of the extrapyramidal syndrome in chronic acquired hepatocerebral degeneration (CAHD).
Papapetropoulos
Spiridon
S
Singer
Carlos
C
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006527:Hepatolenticular Degeneration / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D013747:Tetrabenazine / Q000627:therapeutic use*
D018726:Anti-Dyskinesia Agents; D000978:Antiparkinson Agents; D013747:Tetrabenazine